FONAR CORP (FONR)
US3444374058 - Common Stock
FONR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. While FONR has a great health rating, its profitability is only average at the moment. FONR is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year FONR was profitable.
FONR had a positive operating cash flow in the past year.
In the past 5 years FONR has always been profitable.
Each year in the past 5 years FONR had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 4.24%, FONR belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.33%, FONR is in the better half of the industry, outperforming 78.84% of the companies in the same industry.
FONR has a better Return On Invested Capital (5.54%) than 79.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FONR is in line with the industry average of 8.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 5.33% | ||
| ROIC | 5.54% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
1.3 Margins
With an excellent Profit Margin value of 8.82%, FONR belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
FONR's Profit Margin has declined in the last couple of years.
The Operating Margin of FONR (14.28%) is better than 83.07% of its industry peers.
FONR's Operating Margin has declined in the last couple of years.
FONR's Gross Margin of 42.43% is on the low side compared to the rest of the industry. FONR is outperformed by 65.08% of its industry peers.
FONR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.28% | ||
| PM (TTM) | 8.82% | ||
| GM | 42.43% |
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FONR is destroying value.
FONR has less shares outstanding than it did 1 year ago.
FONR has about the same amout of shares outstanding than it did 5 years ago.
FONR has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.73 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
FONR's Altman-Z score of 2.73 is fine compared to the rest of the industry. FONR outperforms 65.08% of its industry peers.
FONR has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
FONR's Debt to FCF ratio of 0.06 is amongst the best of the industry. FONR outperforms 92.59% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
FONR's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. FONR outperforms 67.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 2.73 |
ROIC/WACC0.59
WACC9.41%
2.3 Liquidity
A Current Ratio of 9.64 indicates that FONR has no problem at all paying its short term obligations.
FONR has a Current ratio of 9.64. This is amongst the best in the industry. FONR outperforms 92.06% of its industry peers.
A Quick Ratio of 9.45 indicates that FONR has no problem at all paying its short term obligations.
FONR's Quick ratio of 9.45 is amongst the best of the industry. FONR outperforms 92.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.64 | ||
| Quick Ratio | 9.45 |
3. Growth
3.1 Past
The earnings per share for FONR have decreased strongly by -14.84% in the last year.
FONR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.12% yearly.
The Revenue has been growing slightly by 0.70% in the past year.
Measured over the past years, FONR shows a small growth in Revenue. The Revenue has been growing by 3.36% on average per year.
EPS 1Y (TTM)-14.84%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%-22.03%
Revenue 1Y (TTM)0.7%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%-3.41%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.57 indicates a reasonable valuation of FONR.
Based on the Price/Earnings ratio, FONR is valued cheaply inside the industry as 95.77% of the companies are valued more expensively.
FONR is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.57 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaply inside the industry as 98.41% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaper than 98.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.54 | ||
| EV/EBITDA | 1.92 |
4.3 Compensation for Growth
FONR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
FONR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FONAR CORP
NASDAQ:FONR (1/14/2025, 8:00:01 PM)
15.16
+0.03 (+0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners49.34%
Inst Owner Change0%
Ins Owners2.18%
Ins Owner Change0%
Market Cap100.81M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio0.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.57 | ||
| Fwd PE | N/A | ||
| P/S | 0.99 | ||
| P/FCF | 9.54 | ||
| P/OCF | 7.68 | ||
| P/B | 0.6 | ||
| P/tB | 0.62 | ||
| EV/EBITDA | 1.92 |
EPS(TTM)1.31
EY8.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.59
FCFY10.48%
OCF(TTM)1.97
OCFY13.02%
SpS15.34
BVpS25.37
TBVpS24.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 5.33% | ||
| ROCE | 7.36% | ||
| ROIC | 5.54% | ||
| ROICexc | 7.63% | ||
| ROICexgc | 8.03% | ||
| OM | 14.28% | ||
| PM (TTM) | 8.82% | ||
| GM | 42.43% | ||
| FCFM | 10.36% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
ROICexc(3y)9.85%
ROICexc(5y)9.62%
ROICexgc(3y)10.45%
ROICexgc(5y)10.24%
ROCE(3y)9.49%
ROCE(5y)9.41%
ROICexcg growth 3Y-5.28%
ROICexcg growth 5Y-14.37%
ROICexc growth 3Y-4.76%
ROICexc growth 5Y-13.51%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
F-Score6
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 26.12% | ||
| Cap/Sales | 2.51% | ||
| Interest Coverage | 416.3 | ||
| Cash Conversion | 53.87% | ||
| Profit Quality | 117.47% | ||
| Current Ratio | 9.64 | ||
| Quick Ratio | 9.45 | ||
| Altman-Z | 2.73 |
F-Score6
WACC9.41%
ROIC/WACC0.59
Cap/Depr(3y)68.94%
Cap/Depr(5y)98.58%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.6%
Profit Quality(3y)113.41%
Profit Quality(5y)133.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.84%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%-22.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.7%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%-3.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.5%
EBIT growth 3Y-1.11%
EBIT growth 5Y-5.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.62%
FCF growth 3Y-4.82%
FCF growth 5Y-3.64%
OCF growth 1Y-21.66%
OCF growth 3Y-9.62%
OCF growth 5Y-6.24%